# The Effect of Mankai on Glycemic Control Among Patients With T2D

Study · id `cardio:ct-nct06416475` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06416475](<https://clinicaltrials.gov/study/NCT06416475>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06416475

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 104 participants.

## Technical summary

Registry record NCT06416475. Randomized; no masking; primary purpose treatment. Start 2024-04-30 (actual); primary completion 2024-08-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 104 participants (enrolled count; ClinicalTrials.gov record NCT06416475, source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)
- Started: 2024-04-30 (actual) (ClinicalTrials.gov record NCT06416475, source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)
- Primary completion: 2024-08-08 (anticipated) (ClinicalTrials.gov record NCT06416475, source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)
- Completion: 2024-08-15 (anticipated) (ClinicalTrials.gov record NCT06416475, source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)
- Countries: Israel (ClinicalTrials.gov record NCT06416475, source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06416475-2024-05-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Effect of Mankai on Glycemic Control Among Patients With T2D
- Condition: Diabetes Mellitus, Type 2
- Intervention (Dietary supplement): Mankai supplementation
- Intervention (Other): Water consumption
- Lead sponsor: Ben-Gurion University of the Negev
- Lead sponsor class: OTHER
- Collaborator: Soroka University Medical Center
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)

## Provenance

Content hash: 78c83495c6f6bac223c0b4d78f40e5773a74b4c3bdf8eaaf1834ec64dc61eeeb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
